Testing Program Clause Samples
Testing Program. The goal of the DFWP is deterrence of illegal drug use through a carefully controlled and monitored program of drug testing. The parties share an interest in ensuring that only those employees who occupy properly identified Testing Designated Positions (TDPs) be subject to random testing and that only those employees selected for properly identified TDPs be subject to pre-employment drug testing.
A. Testing Designated Position (TDP) means a position that has been designated by the Director, DLA, as subject to random drug testing.
1. An employee occupying a TDP will receive written notice that his or her position has been determined to meet the criteria and justification for random drug testing at least 30 days before the individual is subject to unannounced random testing. The notice will include the reason for inclusion, the appeal procedure for requesting review of the designation and the name of a point of contact for questions regarding the decision. In addition, the notice will include a statement that the employee is entitled to Union representation if they choose to appeal their designation.
2. Bargaining unit employees selected for random testing will be selected on the basis of neutral criteria.
3. An employee may appeal the testing designation of his/her position within 30 days following receipt of the written notice, and within 30 days of any material change in the duties of the position. If new information becomes available, an employee may appeal the TDP designation within 30 days of becoming aware of the new information.
B. Types of drug testing are:
1. Random Testing of bargaining unit employees in TDPs and other bargaining unit personnel who volunteer for such tests.
Testing Program. (a) The Seller shall provide to the Purchaser promptly following the Effective Date, and on an on-going basis for any changes, all relevant information regarding its testing program and schedule for the Facility. Not less than thirty (30) Days prior to the commencement of the test program, the Seller shall deliver to the Purchaser in writing the final testing program for the Facility, including a tentative schedule for conducting all tests required under and in relation to this Article 8. If the schedule for any tests is adjusted after the Seller has provided the Purchaser with the final testing program schedule, then the Seller shall advise the Purchaser not less than forty-eight (48) hours prior to the commencement of any such tests. On each Day beginning with the Day on which testing commences, the Seller shall provide the Purchaser with a schedule of the tests to be conducted on the following Day or Days (if such tests will continue for more than one (1) Day). All testing of the Facility shall satisfy the Commissioning Tests and Reliability Run Test provided in this Article 8 and Schedule 6. Representatives from the Purchaser shall have the right to be present at and observe the Commissioning Tests (including the Reliability Run Test) and any retests thereof. Seller shall make reasonable efforts to accommodate Purchaser’s attendance at all tests.
(b) The Facility tests shall be performed in the following sequence:
(i) Testing of the Seller Interconnection Facilities;
(ii) Commissioning Tests; and
(iii) Reliability Run Test.
Testing Program. In the laboratory, all samples will be visually classified and tested according to the INDOT Geotechnical Manual. Laboratory testing of representative samples will be performed in accordance with ASTM/AASHTO procedures to classify existing soils according to the AASHTO Classification System and to estimate engineering properties of importance for pavement design and construction considerations. In addition, the pavement cores will be visually described and photographed. The expected tests to be performed and the estimated quantities are presented in the attached fee schedule. Samples will be retained for a period of sixty (60) days after the completion of the geotechnical report, unless otherwise directed. Pavement cores will be retained until acceptance of the final pavement design report.
Testing Program. The term ‘‘testing program’’ means the alcohol and controlled substances testing program required under title 49, Code of Federal Regulations.
Testing Program. All union members are required to participate in a Random Drug/Alcohol Testing Program as a condition of employment. Those employees currently identified as “safety sensitive” under the Federal DOT regulations, and who participate in the City’s DOT Alcohol and Drug Testing Program are excluded from the Random Drug/Alcohol Testing Program for non-safety sensitive employees. All employees shall be provided with the program guidelines and shall be required to provide the City with confidential contact information. In accordance with current union practice, the testing identification number for each employee shall be his/her driver’s license number. The contact information shall be maintained in a secure location and may be used by Personnel to reach any selected individual if necessary and by the Medical Review Officer should any individual test non- negative at any time.
Testing Program. Verus may from time to time request that the Law Firm submit copies of documents relating to individual claims filings in order to test system quality and for audit purposes. A claim may be selected for quality control testing or audit either before the claim is settled or after a settlement payment has been made. Verus may select some claims for quality control testing or audit randomly, and may select some claims for quality control testing or audit based on other reasons.
Testing Program. (A) The Department created the COVID-19 Testing Program (the “Program”) in order to comply with Ark. Code ▇▇▇. § 11-5-118 (Act 1115 of the 2021 Regular Session, 93rd General Assembly). If made available, SFRF funds will be provided to employers and employees to cover the cost of COVID-19 testing.
(B) Under the Program, an employer or employee may submit a claim for reimbursement of the cost of COVID-19 testing and an employer may submit a request for funding to disburse to employees for reimbursement of the cost of COVID-19 testing.
(C) If SFRF funds are made available, the Program covers the cost of COVID-19 testing not covered by an employee’s health benefit plan for an employee who wishes to continue employment by claiming an exemption under one of the options of the specific exemption process provided for by Ark. Code ▇▇▇. § 11- 5-118 (Act 1115 of the 2021 Regular Session, 93rd General Assembly). No administrative costs are eligible costs under the Program.
(D) Before an employer may receive SFRF funds, the employer must provide the Department with an executed Subrecipient Agreement and establish itself as a state vendor through the Department or its successor.
(E) An employer that receives SFRF funds is a Subrecipient and is subject to the compliance and reporting responsibilities required by the American Rescue Plan Act. The COVID-19 Testing Program Subrecipient Agreement is an addendum to this rule.
(F) Before an employee may receive SFRF funds, the employee must establish himself or herself as a state vendor through the Department or its successor.
(G) If an employer or employee has not been established as a state vendor, payment for a reimbursement claim or an employer’s request for funding will be delayed.
(H) SFRF funds received under the Program are subject to repayment to the Department for the following reasons: SFRF funds are used for an ineligible purpose; the Department determines an employer has received an excess of funding based upon analysis of the monthly reports; in the event of separation of employees; or as provided by the COVID-19 Testing Program Subrecipient Agreement.
Testing Program. All test decisions involve consultation with the contractor supervisor or management representative (if available) and Vale management. All persons on premises are subject to testing in the following select circumstances:
Testing Program. MFR may from time to time request that the Law Firm submit copies of documents relating to individual claims filings in order to test system quality and for audit purposes. A claim may be selected for quality control testing or audit either before the claim is settled or after a settlement payment has been made. MFR may select some claims for quality control testing or audit randomly, and may select some claims for quality control testing or audit based on other reasons.
Testing Program. The Contractor agrees to establish, implement, and execute a drug and alcohol testing program as approved by RED, that complies with the San Francisco Police Code Section 3300A.5, and produce any documentation necessary to establish its compliance with Section 33000A.5. The testing program should meet at least the following minimum standards:
i. A policy explaining your company’s drug and alcohol use policy, the various testing requirements, including procedures and consequences for those employees who test positive, and the name of the third-party administrator that your company uses to perform these tests. The policy must be distributed to all of the Contractor's employees who provide Guard Services;
ii. Training of all employees subject to the Drug and Alcohol Screening Policy. Supervisors who may make reasonable suspicion determinations need additional training on the indicators of probable drug use and alcohol misuse;
iii. Referral of employees who test positive to a Substance Abuse Professional;
iv. Record-keeping and reporting: retain records of drug and alcohol testing, and provide reports to RED if requested.
v. All tests and re-tests shall be done at no additional charge to the City for the duration of this Contract and any extensions issued thereafter.
vi. A positive test shall result in immediate removal of the guard from duty by Contractor.